23 Oct
|
Heng & Hurst
|
Sydney
23 Oct
Heng & Hurst
Sydney
This is an opportunity to join a global biopharma organisation focused on developing innovative treatments for patients with complex and serious conditions. With a strong pipeline and established portfolio, the business is committed to ensuring patients can access the therapies they need through effective market access and reimbursement strategies.
About the Role Reporting to the Head of Market Access, ANZ, the Senior Market Access Manager will lead the development and execution of pricing and reimbursement strategies across Australia and New Zealand.
Working closely with cross-functional teams across Market Access, Medical, Marketing and External Affairs, you will contribute to both launch and lifecycle strategies, ensuring reimbursement approaches are aligned with local healthcare requirements, global objectives and evolving policy changes.
Key Responsibilities
- Lead the preparation and delivery of reimbursement submissions to PBAC, MSAC and PHARMAC, including supporting evidence development and submission strategy.
- Develop pricing and reimbursement strategies for recent products, pipeline assets and existing therapies.
- Evaluate clinical, economic and real-world evidence to inform HTA submissions and market access decisions.
- Identify evidence gaps and recommend data generation strategies to strengthen reimbursement outcomes.
- Provide strategic pricing advice, including pricing approvals, price disclosure, statutory price reductions and managed entry agreements.
- Monitor changes to Australian and New Zealand reimbursement policies and translate these into practical access strategies.
- Partner with cross-functional teams to integrate Market Access considerations into brand planning,
product launches and lifecycle management.
- Build and maintain relationships with key external stakeholders, including government departments, reimbursement bodies and industry groups.
- Contribute to business planning, competitive analysis and pipeline assessments, identifying opportunities and risks that may impact future access.
You will bring:
- At least 5 years' experience in the pharmaceutical or biotechnology industry, within pricing, reimbursement or market access.
- Strong knowledge of the PBS, PBAC and MSAC processes, alongside an understanding of New Zealand's PHARMAC funding framework.
- Experience developing reimbursement submissions and navigating HTA requirements.
- The ability to critically assess clinical, health economic and real-world evidence to inform access strategies.
- Strong commercial acumen, with the ability to identify pricing risks and evaluate reimbursement opportunities.
- Excellent communication, stakeholder engagement and influencing skills.
- A collaborative approach and the ability to work effectively across local, regional and global teams.
- A bachelor's degree in a relevant discipline, with a master's degree in health economics, public health, epidemiology or a related analytical field highly regarded.
This is an opportunity to take on a high-impact Market Access role where your expertise will directly contribute to the availability of innovative therapies for patients. You'll have the opportunity to influence reimbursement strategy from pipeline planning through to product launch and lifecycle management, while working alongside experienced cross-functional teams in a global environment.
#J-18808-Ljbffr
📌 NSW | Senior Market Access Manager | Sydney - 12 Month Contract
🏢 Heng & Hurst
📍 Sydney